Managing Director (in ch.), NCT Heidelberg
Head: Molecular and Cellular Oncology
Phone: +49 6221 56-6990/-35212
Fax: +49 6221 56-6967
Since April 2018, Professor Stefan Fröhling has been Acting Managing Director of NCT Heidelberg. In addition, he heads the Molecular and Cellular Oncology group at NCT/DKFZ. Stefan Fröhling’s research aims at providing as many patients as possible with individually tailored cancer treatments. As part of the NCT Precision Oncology Program (NCT POP), much of his work is centered on the development of tools for the comprehensive molecular and functional characterization of individual tumors, and the conception of clinical studies examining the efficacy of modern, molecularly targeted treatment approaches. In addition to his research in the precision oncology field, Stefan Fröhling particularly focuses on the biology of bone and soft-tissue sarcomas as well as acute forms of leukemia.